Evidence map›Paper›PMID 20421335›Full record

ArticleSchizophrenia bulletin2010

TCF4, schizophrenia, and Pitt-Hopkins Syndrome.

Derek J Blake, Marc Forrest, Ria M Chapman, Caroline L Tinsley, Michael C O'Donovan, Michael J Owen

Open access · bronzeAbstract readEditorial
In one paragraph

Article in Schizophrenia bulletin, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. The Journal of international medical research · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  18. Article
  19. Article
  20. Knockdown of the schizophrenia susceptibility geneJournal of psychiatry & neuroscience : JPN · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Derek J BlakeDepartment of Psychological Medicine and Neurology, Medical Research Council Center for Neuropsychiatric Genetics and Genomics, Cardiff University, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, UK. blakedj@cardiff.ac.uk
Marc Forrest
Ria M Chapman
Caroline L Tinsley
Michael C O'Donovan
Michael J Owen
Cardiff University · GBMedical Research Council · GB

Funding

Medical Research Council G0800509Wellcome Trust WT088866
6 · The paper itself

Abstract

Genome-wide association studies allied with the identification of rare copy number variants have provided important insights into the genetic risk factors for schizophrenia. Recently, a meta-analysis of several genome-wide association studies found, in addition to several other markers, a single nucleotide polymorphism in intron 4 of the TCF4 gene that was associated with schizophrenia. TCF4 encodes a basic helix-loop-helix transcription factor that interacts with other transcription factors to activate or repress gene expression. TCF4 mutations also cause Pitt-Hopkins Syndrome, an autosomal-dominant neurodevelopmental disorder associated with severe mental retardation. Variants in the TCF4 gene may therefore be associated with a range of neuropsychiatric phenotypes, including schizophrenia. Recessive forms of Pitt-Hopkins syndrome are caused by mutations in NRXN1 and CNTNAP2. Interestingly, NRXN1 deletions have been reported in schizophrenia, whereas CNTNAP2 variants are associated with several neuropsychiatric phenotypes. These data suggest that TCF4, NRXN1, and CNTNAP2 may participate in a biological pathway that is altered in patients with schizophrenia and other neuropsychiatric disorders.

Indexed as

Abnormalities, MultipleAllelesAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBrainChromosome AberrationsChromosome DeletionDevelopmental DisabilitiesDNA Mutational AnalysisGenes, DominantGenes, RecessiveGenetic Carrier ScreeningGenetic MarkersGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGenetic MarkersTCF4 protein, humanTranscription Factor 4Transcription Factors

Identifiers

PMID20421335
PMCPMC2879683
OpenAlexW2159892916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.